Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-576P is a **pseudogene** originating from the U6 small nuclear RNA gene family[2][5][6]. U6 snRNA itself is a highly conserved non-coding RNA component of the spliceosome responsible for the excision of introns from pre-mRNA in the nucleus of eukaryotes[3][1]. However, pseudogenes like RNU6-576P do not encode functional RNA, proteins, or contribute directly to this process. Instead, they result from gene duplication or retrotransposition events and usually contain sequence similarity to the functional parent gene, such as possessing authentic 5’- and 3’-ends or internal repeats but lacking biological activity[5][6]. In genomic studies, RNU6-derived pseudogenes are considered important for understanding genome evolution and retrotransposition dynamics but not as molecular targets for therapy or diagnostics[6]. If you seek a genuine molecular target, reference should be made to the functional U6 snRNA gene (e.g., RNU6-1)[3][1].\n\nThis locus is **not a receptor, enzyme, transporter, transcription factor, or direct therapeutic target**. No drugs interact with it, and it is not used as a biomarker. It is listed here only because of its origin as a U6 snRNA pseudogene, and there is no current evidence for its involvement in human disease or drug response. If your intended query concerns the functional U6 snRNA, that entity has a well-defined role in pre-mRNA splicing[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 576, pseudogene (RNU6-576P).